Today we are talking to JeanFrancois Formela. I have known JF for over 2 decades having worked with him at Atlas in building multiple biotech companies. JF is a partner at Atlas Venture which he joined in 1993 to build the US LS presence which has ultimately become the Atlas we all know today. He co-founded, invested in and played pivotal roles in a multitude of companies including Intellia Therapeutics, IFM Therapeutics, Korro Bio, Triplet and others. Other key investments he has made include Exelixis, Adnexus (acqd byBMS), Arteaus (acqd by Eli Lilly), CoStim Pharmaceuticals (acqd byNovartis) and Translate Bio (acqd by Sanofi).
JF got his MD from Paris University School of Medicine and an MBA from Columbia. He is a wine connoisseur and lives close to the edge racing on the track.
Please join me in welcoming JF.
Today we are talking to JeanFrancois Formela. I have known JF for over 2 decades having worked with him at Atlas in building multiple biotech companies. JF is a partner at Atlas Venture which he joined in 1993 to build the US LS presence which has ultimately become the Atlas we all know today. He co-founded, invested in and played pivotal roles in a multitude of companies including Intellia Therapeutics, IFM Therapeutics, Korro Bio, Triplet and others. Other key investments he has made include Exelixis, Adnexus (acqd byBMS), Arteaus (acqd by Eli Lilly), CoStim Pharmaceuticals (acqd byNovartis) and Translate Bio (acqd by Sanofi).
JF got his MD from Paris University School of Medicine and an MBA from Columbia. He is a wine connoisseur and lives close to the edge racing on the track.
Please join me in welcoming JF.